Who is sponsoring NCT00221468?

NCT00221468 is sponsored by University of Cincinnati.

What condition does NCT00221468 study?

NCT00221468 studies Mood Disorders.

What is the status of NCT00221468?

NCT00221468 is currently COMPLETED.

Last reviewed 2012-07-17 · How we verify

A Single-Blind Prospective Study of Quetiapine for the Treatment of Mood Disorders in Adolescents

NCT00221468 Phase 3 COMPLETED

The purpose of this research study is to obtain preliminary data regarding the effectiveness, tolerability, and safety of quetiapine therapy for adolescents who have a mood disorder and have at least one parent with bipolar disorder (severe mood swings).

Details

Lead sponsor	University of Cincinnati
Phase	Phase 3
Status	COMPLETED
Enrolment	20
Start date	2003-06
Completion	2006-04

Conditions

Mood Disorders

Interventions

quetiapine

Primary outcomes

Clinical Global Impression Improvement (CGI) — 12 weeks
The Clinical Global Impression Improvement Score of \< 2 (much or very much improved) will be used to quantify the adolescent's change in overall severity of illness.

Countries

United States